The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.

Thyroid : official journal of the American Thyroid Association

Volumn 20, Issue 7, 2010, Pages 681-687

  Ross, Colin J D ^a   Visscher, Henk ^b   Sistonen, Johanna ^b   Brunham, Liam R ^b   Pussegoda, Kusala ^b   Loo, Tenneille T ^b   Rieder, Michael J ^b   Koren, Gideon ^b   Carleton, Bruce C ^b   Hayden, Michael R ^b   CPNDS Consortium, ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CISPLATIN; CODEINE; PHARMACOLOGICAL BIOMARKER;

ADULT; CANADA; CHILD; DRUG SURVEILLANCE PROGRAM; DRUG TOXICITY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SCREENING; GENETICS; HEALTH SURVEY; HUMAN; INTERNATIONAL COOPERATION; METHODOLOGY; MORTALITY; PERSONALIZED MEDICINE; PHARMACOGENETICS; REVIEW; SENTINEL SURVEILLANCE;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTITHYROID AGENTS; BIOMARKERS, PHARMACOLOGICAL; CANADA; CHILD; CISPLATIN; CODEINE; DRUG TOXICITY; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC TESTING; HUMANS; INDIVIDUALIZED MEDICINE; INTERNATIONAL COOPERATION; PHARMACOGENETICS; POPULATION SURVEILLANCE; SENTINEL SURVEILLANCE;

EID: 78349268004     PISSN: None     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2010.1642     Document Type: Review

References (0)